Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Príomhchruthaitheoir: | Tamanna, Mst. Taskia |
---|---|
Rannpháirtithe: | Sharmin, Dr. Sabrina |
Formáid: | Tráchtas |
Teanga: | English |
Foilsithe / Cruthaithe: |
Brac University
2023
|
Ábhair: | |
Rochtain ar líne: | http://hdl.handle.net/10361/18146 |
Míreanna comhchosúla
-
Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
de réir: Hassan, Md. Muhtaz
Foilsithe / Cruthaithe: (2020) -
Role of protein’s and future treatment options for Alzheimer’s Disease
de réir: Islam, Md. Irfath
Foilsithe / Cruthaithe: (2023) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
de réir: Alim, Abdul
Foilsithe / Cruthaithe: (2023) -
Marine compounds in the treatment of Alzheimer’s disease
de réir: Parveen, Sanjana
Foilsithe / Cruthaithe: (2022) -
Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
de réir: Tabassum, Nadira
Foilsithe / Cruthaithe: (2024)